HealthResearchers Develop Anti-Cancer Drug to Treat Acute Myeloid Leukemia Revumenib sheds light on AML patients as the drug potentially treats their cancer. A group of researchers conducted phase one of clinical trials between 2019 to 2022 for an anti-cancer drug on patients living with acute myeloid leukemia (AML).by Inno Flores
Healthy Living/WellnessMidostaurin In AML Improves Survival In Newly Diagnosed AML Patientsby Rina Marie Doctor